Autolus Therapeutics Plc (AUTL)
1.41
+0.03
(+2.17%)
USD |
NASDAQ |
Apr 02, 16:00
1.41
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics EPS Diluted (Quarterly) : -0.3389 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Mereo BioPharma Group Plc | -0.0461 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.7979 |
| Bicycle Therapeutics Plc | -0.2901 |
| DBV Technologies SA | -1.170 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -90.20M |
| Revenue (Quarterly) | 24.25M |
| Total Expenses (Quarterly) | 114.46M |
| Enterprise Value | 424.64M |
| Gross Profit Margin (Quarterly) | -4.29% |
| Profit Margin (Quarterly) | -371.9% |
| Earnings Yield | -74.45% |
| Normalized Earnings Yield | -74.39 |